AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of Optimized Development Solutions.
Fler avsnitt av The Medical AI Podcast
Visa alla avsnitt av The Medical AI PodcastThe Medical AI Podcast med Dr. Felix Beacher finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
